Literature DB >> 6185577

Cyclic AMP as a mediator of prostaglandin E-induced suppression of human natural killer cell activity.

T Goto, R B Herberman, A Maluish, D M Strong.   

Abstract

The role of cyclic AMP in mediating the prostaglandin (PG) E2-induced suppression of natural killer (NK) cell function was studied. Highly purified preparations of human large granular lymphocytes (LGL; which have been shown to be closely associated with human NK activity) and T lymphocytes were obtained by using Percoll gradients. Basal cyclic AMP was similar in both cell populations. With LGL, PGE2 (but not PGF2 alpha) suppressed NK activity (75%) and enhanced cellular cycle AMP (600%). In contrast, in small, high density T lymphocytes, PGE2 caused very small increases in cyclic AMP (20%). Phosphodiesterase inhibitors (PDEI) such as isobutyl methylxanthine and theophylline also increased cyclic AMP and suppressed NK activity in LGL. The effect of PGE2 and PDEI, in combination on cellular cyclic AMP and NK activity, was greater than the effect of each agent alone. Finally, exogenous derivatives of cyclic AMP also suppressed NK activity. These results indicate that in LGL, increased cellular cyclic AMP mediates the action of PGE2 on the suppression of NK activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185577

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  In vitro atrazine-exposure inhibits human natural killer cell lytic granule release.

Authors:  Alexander M Rowe; Kathleen M Brundage; John B Barnett
Journal:  Toxicol Appl Pharmacol       Date:  2007-02-07       Impact factor: 4.219

2.  Evidence for prostaglandin-producing supressor cells in HCV patients with normal ALT.

Authors:  Rui Marinho; Ruth Pinto; Maria Livia Santos; MouraMiguelCarneiro de
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

3.  Intracellular contents of cyclic nucleotides in neutrophils and lymphocytes from patients with systemic lupus erythematosus.

Authors:  M Shingu; K Tatsukawa; M Nobunaga
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

4.  Decreased natural killer cell activity in atopic eczema.

Authors:  T J Hall; R Rycroft; J Brostoff
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

5.  Natural killer-like activity in human cultured lymphoid cells propagated in the presence of interleukin-2: acquired resistance to prostaglandin E2- or dexamethasone-mediated suppression.

Authors:  H Suzuki; N Yamashita; M Sato; M Iwata; M Maruyama; S Yano
Journal:  Experientia       Date:  1985-05-15

6.  Effects of aspirin, dipyridamole, and cod liver oil on accelerated myointimal proliferation in canine veno-arterial allografts.

Authors:  W M DeCampli; J C Kosek; R S Mitchell; C E Handen; D C Miller
Journal:  Ann Surg       Date:  1988-12       Impact factor: 12.969

Review 7.  T regulatory cells in B-cell malignancy - tumour support or kiss of death?

Authors:  Camilla A Lindqvist; Angelica S I Loskog
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

Review 8.  Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

9.  A high level of prostaglandin E2 (PGE2) in the portal vein suppresses liver-associated immunity and promotes liver metastases.

Authors:  K Okuno; H Jinnai; Y S Lee; K Nakamura; T Hirohata; H Shigeoka; M Yasutomi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 10.  Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology.

Authors:  Hedi Harizi
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.